Here’s More Evidence That Coffee Is Good For Your Brain
I know by now news on coffee research is a little hard to swallow, considering how often new studies come out with contradictory conclusions. But don’t give up on coffee […]
This author has not written his bio yet.
But we are proud to say that Forbes Health contributed 272 entries already.
I know by now news on coffee research is a little hard to swallow, considering how often new studies come out with contradictory conclusions. But don’t give up on coffee […]
Many of the drugs that are sold over-the-counter (OTC) began life as prescription medications. Anti-ulcer/heartburn drugs such as the histamine H2 antagonist, Zantac, and the proton-pump inhibitor, Prilosec, were first […]
What do you get when you combine Obamacare with an expected explosion in the use of pricey drugs and the rapid aging of the Baby Boomer population? The answer, courtesy […]
Twenty-seven years ago George Yancopoulos was a scientific superstar, a professor of biology at Columbia at age 28. But his father, a first-generation Greek immigrant, kept complaining about how little […]
Teva Pharmaceutical Industries may have found the deal it wanted in purchasing Allergan’s generics business for $40.5 billion in cash and stock, but the Israeli pharmaceutical company stands to lose around $300 […]
At age 45, Allergan Chief Executive Brent Saunders already pulled off something like $150 billion worth of deals. Now he’s going to get ready to do it again. Last year alone Saunders […]
Anthem and Cigna, which announced a $54 billion merger on Friday morning, probably won’t be able to consummate their deal for at least a year. Regulators are beginning to closely scrutinize the two […]
The Food and Drug Administration has approved Praluent, a new medicine to lower cholesterol in people who have established heart disease, for people whose risk of a heart attack or […]
Loneliness accelerates cognitive decline in older adults, says a research team presenting at the Alzheimer’s Association International Conference in Washington, D.C. The findings build on recent research indicating that late-life depression […]
News that Anthem (ANTM) will buy Cigna (CI) for $54 billion– a deal that closely follows the proposed merger of Aetna (AET) and Humana (HUM) — will intensify regulators’ focus […]